XML 61 R46.htm IDEA: XBRL DOCUMENT
v3.23.1

Forward and Swap Contracts (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2023
Notes To Financial Statements [Abstract] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value |
|  | Asset Derivatives |  | Liability Derivatives
|  | Fair Value at |  | Fair Value at |  | Fair Value at |  | Fair Value at
Balance Sheet Location |  | March 31, 2023 |  | March 31, 2022 |  | March 31, 2023 |  | March 31, 2022
Prepaid & Other |  | $ | 378 |  |  | $ | 2,780 |  |  | $ | — |  |  | $ | — |
Accrued expenses and other |  | — |  |  | — |  |  | 2,054 |  |  | 198 |
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following table presents the impact of derivative instruments and their location within the Consolidated Statements of Income:
|  | Location of (loss) gain recognized in income |  | Amount of (loss) gain recognized in income
Years Ended March 31,
2023 |  | 2022 |  | 2021
Foreign currency forward contracts |  | Selling, general, and administrative |  | $ | 5,036 |  |  | $ | 4,379 |  |  | $ | 1,178 |
Commodity swap contracts |  | Cost of revenues |  | (3,630) |  |  | 3,921 |  |  | 771 |

X
- Definition Notes to Financial Statements [Abstract] + References No definition available. + Details
Name: | ste_NotesToFinancialStatementsAbstract
Namespace Prefix: | ste_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration